VANCOUVER, British Columbia, April 18, 2019 – Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or “OFIG” or the “Company”) is pleased to announce it has entered into a binding letter of intent (“LOI”), dated April 17th, 2019, to acquire the exclusive rights to a portfolio of disruptive cannabis beverage assets and intellectual property (“IP”). This acquisition will position Organic Flower as the industry’s sole Canadian manufacturer and distributor of an innovative beverage dispensing cap technology, equipped with a proprietary cannabinoid delivery mechanism.
DISRUPTIVE DISPENSING CAP TECHNOLOGY
Organic Flower’s cannabis-infused beverages will leverage patented pharmaceutical-grade dispensing cap technology, as well as advanced delivery mechanisms to provide optimized ingredient effectiveness for the end consumers. With a simple twist of the cap, this intuitive technology enables the blending of premium, preserved cannabinoids into an assortment of bottled liquids; ensuring the consumer receives the full range of functional benefits at the moment of consumption.
The state-of-the-art delivery technology is certified for healthcare and pharmaceutical applications; Organic Flower anticipates that it will pioneer an elevated industry standard of quality. The delivery mechanism boasts a patented airtight and moisture-resistant bottle cap to protect volatile ingredients such as cannabinoids, antibiotics, probiotics, vitamins and minerals resulting in superior shelf stability for infused bottled beverages. The dispensing cap technology allows for increased efficacy when compared to pre-mixed beverages, which are susceptible to rapid nutrient deterioration.
Refined over five years, with research and development expenditures of $30 million, Organic Flower will leverage its exclusive rights to a marquee dispensing cap technology and delivery mechanism to revolutionize the North American cannabinoid-infused beverage marketplace.
Organic Flower plans to offer thoughtfully curated beverage blends to enhance human performance with three core formulations – Energy, Relax and Recover. The Company has paired the advanced cap technology with market tested formulations to develop drinks that are expected to lead innovation in the cannabis-infused beverage industry.
Organic Flower will foster the ultimate infused beverage experience, while focusing on what consumers care about most:
- POTENCY: Nutrients degrade when exposed to heat, moisture, and light. The cap protects activities of the powerful cannabis ingredients and helps to retain their potency;
- EFFECTIVENESS: Only premium, science-based, most effective active ingredients have been used in combination with expertly developed formulations; and,
- FRESHNESS: These proprietary bottled beverages offer the freshest and crispest flavors, aromas and color by keeping them protected from light and moisture, delivering an amazing drinking experience.
Joel Dumaresq, Chief Executive Officer of Organic Flower stated: “We take great pride in the careful selection of our essential ingredients, so that we can assure the highest quality is provided to consumers and our beverages maintain and maximize absorption for maximum enjoyment. The cannabinoid-infused beverages market is forecasted to reach US$600 million over the next four years and the acquisition of the exclusive Canadian rights to a suite of disruptive cannabis beverage assets and IP affords OFIG the opportunity to capture significant market share in Canada’s nascent infused beverage industry”.
Upon closing of the transaction, Organic Flower will issue 9.166 million common shares, based upon the five-day VWAP of OFIG’s common shares for the five trading sessions prior to the announcement of the definitive agreement.
The exclusive licensing agreement will extend for an initial period of 10-years. Organic Flower may also extend the exclusive licensing agreement for an additional successive 10-year term. The Company may pay a finders fee upon closing of the transaction.
ABOUT ORGANIC FLOWER INVESTMENTS
Leveraging strategic relationships, proprietary investments and exclusive partnerships with preeminent international cannabis cultivators and formulators for the development of best in class products and brands to be marketed and distributed throughout our global footprint.
Via its wholly owned subsidiary, Delta Organic Cannabis (“DOC”), Organic Flower is launching one of the largest and most efficient cannabis facilities on the planet. Organic Flower has control or direction over 44,852,040 common shares of AgraFlora Organics International Inc. (“Agra”), representing 10.12 per cent of the issued and outstanding share capital of Agra on a non-diluted basis.
ON BEHALF OF THE ORGANIC FLOWER INVESTMENTS GROUP INC. BOARD OF DIRECTORS
+1 (604) 687-2038
Learn more about Organic Flower by visiting our website at: https://sowcannabis.ca/
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
Notice Regarding Forward Looking Information:
This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: political changes in Canada and internationally, future legislative and regulatory developments involving cannabis in Canada and internationally, the Company’s ability to secure distribution channels in international jurisdictions, competition and other risks affecting the Company in particular and the cannabis industry generally.
The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward- looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.